Programs Project for Regenerative / Cellular Medicine and Gene Therapies
This project supports basic research on regenerative medicine/cell therapy, non-clinical and clinical research, development of foundational manufacturing technology, research utilizing disease-specific iPSCs, and establishment of necessary foundational structures for research, as well as R&D in the field of gene therapy.
List of our Programs
|Research Center Network for Realization of Regenerative Medicine||This program promotes the practical application of iPS cells, etc. by establishing a research system that facilitates research on safety and standards, the construction of iPS cell stock for regenerative medicine, and aims for realization of regenerative medicine by disease and tissue. It aims to connect regenerative medicine and drug discoveries using iPS cells, etc. for clinical applications, prior to their introduction to the world.|
|Research Project for Practical Applications of Regenerative Medicine||The goal of the program is to bring cutting-edge regenerative medicine into full-scale practical use in Japan ahead of other countries.|
|Regenerative Medicine Seeds Development Booster Support||This project aims to facilitate the speedy industrialization of regenerative medicine products by supporting companies including venture businesses that develop regenerative medicine product seeds to establish non-clinical trial procedures and manufacturing methods that comply with the regulatory requirements, which will be necessary for clinical development.|
|Development of models for stable supply of domestic allogenic human somatic stem cell materials||To ensure the stable supply of (allogeneic) human somatic stem cell materials from domestic medical institutions, this project aims to address issues related to the supply of human cell materials and develop models for a self-sustainable supply system.|
|Foundational Technology Development for the Promotion of Regenerative Medicine Industrialization||This project aims to develop scale-up technology for production while thoroughly examining the stability and equivalence during the manufacture of regenerative medicine products, efficiency of manufacturing through mechanization and automation, and cost reduction related to manufacturing.
It also aims to foster talent in businesses with extensive knowledge on the establishment of production methods, quality management, and regulatory requirements.
|Research and development of core technologies for gene and cell therapy||This project will integrate advanced key technologies scattered in Japan into core centers to develop new large-scale vector production methods, create a network of research centers with these large-scale production technologies, and establish a basis for research on novel gene/cell therapy with the overarching goal of its eventual clinical application. Another goal is the acceleration of R&D on advanced gene/cell therapy by creating new technologies for high-quality production and improved safety required to reach clinical use.|
|Practical Research for Innovative Cancer Control||This research program promotes development of technologies for the prevention and early detection of cancer.|
|Practical Research Project for Rare / Intractable Diseases||The goal of this project is to promote the elucidation of the causes of intractable diseases.|
List of Terminated Program
|Project to Build Foundation for Promoting Clinical Research of Regenerative Medicine||The project provides support in technical matters, development of human resources, database creation, and other areas for clinical research initiatives undertaken by universities and medical institutions with knowledge and experience in regenerative medicine.|
|Project Focused on Developing Key Evaluation Technology : Development of Platform Technology for Drug Discovery through Application of Regenerative Medicine||AMED has been promoting the support tools for drug discovery using the induced pluripotent stem (iPS) cell-based technology to improve the efficiency of new drug discovery in “Japan Regenerative Medicine Project.|
Last updated 10/28/20